未登录 分享 收藏
分享 收藏
分享 收藏
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey 指导晚期尿路上皮癌一线治疗决策：一项全球调查 Grande, Enrique; Bellmunt, Joaquim; Hussain, Syed A.; Al Mansour, Mubarak M.; Bamias, Aristotle; Barthelemy, Philippe; Benjamin, David J.; Blais, Normand; Bourlon, Maria T.; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Felix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C.; Matsubara, Nobuaki; Merseburger, Axel S.; Mukherji, Deborah; Park, Chandler H.; Tran, Ben; da Trindade, Karine Martins; Urun, Yuksel; Kamat, Ashish M.; Birtle, Alison J. 分享 收藏
UK multidisciplinary recommendations on use of combination first-line enfortumab vedotindel and pembrolizumab in advanced urothelial carcinoma 英国多学科关于在晚期尿路上皮癌中使用恩沃利单抗联合帕博利珠单抗作为一线治疗的建议 Hussain, Syed; Carr, Aisling; Crabb, Simon John; Dodhia, Vikash; Fearfield, Louise; Malik, Jahangeer Mahmood; Lapuente, Maria; Lau, Davina; Petruskin, Harry; Sarwar, Naveed; Smith, Nicola Jane; Stevenson, Robert; Jones, Robert 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Nano-protected form of rosemary essential oil has a positive influence on blood biochemistry parameters, haematological indices, immune-antioxidant status, intestinal microbiota and histomorphology of meat-type chickens Adil, Sheikh; Banday, Muhammad T.; Wani, Manzoor A.; Hussain, Syed A.; Shah, Showkat; Sheikh, Islam D.; Shafi, Majid; Khan, Azmat A.; Kashoo, Zahid A.; Pattoo, Roof A.; Swelum, Ayman A. 分享 收藏
Real-word outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial 高风险非肌层浸润性膀胱癌的真实结果: BRAVO试验的筛查患者 Conroy, Samantha; Jubber, Ibrahim; Noon, Aidan P.; Rosario, Derek J.; Griffin, Jon; Morgan, Susan; Hubbard, Rachel; Kennish, Steve; Mitchell, Stephen; Venugopal, Suresh; Linton, Kate; Rajasundaram, Ramanan; Hussain, Syed A.; Catto, James W. F. 分享 收藏
分享 收藏
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial Smith, Tim A. D.; West, Catharine M. L.; Joseph, Nuradh; Lane, Brian; Irlam-Jones, Joely; More, Elisabet; Mistry, Hitesh; Reeves, Kimberley J.; Song, Yee Pei; Reardon, Mark; Hoskin, PeterJ.; Hussain, Syed A.; Denley, Helen; Hall, Emma; Porta, Nuria; Huddart, Robert A.; James, Nick D.; Choudhury, Ananya 分享 收藏
Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial Griffin, Jon; Down, Jenny; Quayle, Lewis A.; Heath, Paul R.; Gibb, Ewan A.; Davicioni, Elai; Liu, Yang; Zhao, Xin; Swain, Jayne; Wang, Dennis; Hussain, Syed; Crabb, Simon; Catto, James W. F. 分享 收藏
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective 尿路上皮癌的全身抗癌治疗: 英国肿瘤学家的观点 Jones, Robert J.; Crabb, Simon J.; Linch, Mark; Birtle, Alison J.; McGrane, John; Enting, Deborah; Stevenson, Robert; Liu, Kin; Kularatne, Bihani; Hussain, Syed A. 分享 收藏
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer 厄达替尼在卡介苗治疗的高危非肌层浸润性膀胱癌中的应用 Catto, J. W. F.; Tran, B.; Roupret, M.; Gschwend, J. E.; Loriot, Y.; Nishiyama, H.; Redorta, J. P.; Daneshmand, S.; Hussain, S. A.; Cutuli, H. J.; Procopio, G.; Guadalupi, V.; Vasdev, N.; Naini, V.; Crow, L.; Triantos, S.; Baig, M.; Steinberg, G. 分享 收藏
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker Selection Meeks, Joshua J.; Black, Peter C.; Galsky, Matthew; Grivas, Petros; Hahn, Noah M.; Hussain, Syed A.; Milowsky, Matthew I.; Steinberg, Gary D.; Svatek, Robert S.; Rosenberg, Jonathan E. 分享 收藏
THOR-2 cohort 1: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients (pts) with high-risk non emuscle-invasive bladder cancer (HR NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior bacillus calmette-guerin (BCG) treatment Catto, J. W. F.; Tran, B.; Roupret, M.; Gschwend, J. E.; Loriot, Y.; Nishiyama, H.; Palou, J.; Daneshmand, S.; Hussain, S. A.; Cutuli, H. J.; Procopio, G.; Guadalupi, V.; Vasdev, N.; Naini, V.; Crow, L.; Triantos, S.; Baig, M.; Steinberg, G. D. 分享 收藏
DISCUS: A randomised phase II study of 3 vs 6 cycles of chemotherapy followed by maintenance avelumab in advanced urothelial cancer - Wearable devices and circulating biomarkers assessing quality of life and surrogate efficacy endpoints Jackson-Spence, F.; Pinto Marin, A.; Puente, J.; Molina-Cerrillo, J.; Hussain, S. A.; Ackerman, C.; Bonsu, N.; Kelly, J.; Loriot, Y.; Powles, T. B.; Grande Pulido, E. 分享 收藏
phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2) II期研究新辅助阿特珠单抗在非尿路上皮，肌肉浸润性膀胱癌中的安全性和有效性 (ABACUS-2) Szabados, B. E.; Nogueron Martinez, E.; Alvarez Marquez, F. J.; Castellano Gauna, D. E.; Rodriguez-Vida, A.; Garcias de Espana, M. C.; Hussain, S. A.; Alvarez Fernandez, C.; Linch, M.; Bonfill Abella, T.; Goupil, M. Gross; Kelly, J.; Jones, R. J.; Crabb, S.; Beltran, L.; Garonce-Hediger, R.; Rakebrandt, N. J.; Georgescu, R.; Ackerman, C.; Powles, T. B. 分享 收藏
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer Macaulay, Valentine M.; Lord, Simon; Hussain, Syed; Maroto, Jose Pablo; Jones, Robert Hugh; Climent, Miguel Angel; Cook, Natalie; Lin, Chia-Chi; Wang, Shian-Shiang; Bianchini, Diletta; Bailey, Mark; Schlieker, Laura; Bogenrieder, Thomas; de Bono, Johann 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏